23Andme Total Liab from 2010 to 2024

ME Stock  USD 3.48  0.13  3.60%   
23Andme Holding's Total Liabilities is decreasing over the years with very volatile fluctuation. Overall, Total Liabilities is expected to go to about 316.4 M this year. Total Liabilities is the total amount of all liabilities that 23Andme Holding Co has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
206.6 M
Current Value
316.4 M
Quarterly Volatility
195.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 23Andme Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 23Andme Holding's main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.9 M, Interest Expense of 11.6 M or Selling General Administrative of 104.6 M, as well as many indicators such as Price To Sales Ratio of 23.98, Dividend Yield of 0.0 or PTB Ratio of 27.94. 23Andme financial statements analysis is a perfect complement when working with 23Andme Holding Valuation or Volatility modules.
  
Check out the analysis of 23Andme Holding Correlation against competitors.

Latest 23Andme Holding's Total Liab Growth Pattern

Below is the plot of the Total Liab of 23Andme Holding Co over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. 23Andme Holding's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 23Andme Holding's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Very volatile
   Total Liab   
       Timeline  

23Andme Total Liab Regression Statistics

Arithmetic Mean383,477,951
Geometric Mean354,713,213
Coefficient Of Variation50.99
Mean Deviation88,565,207
Median382,882,000
Standard Deviation195,551,786
Sample Variance38240.5T
Range841.1M
R-Value(0.09)
Mean Square Error40843.3T
R-Squared0.01
Significance0.75
Slope(3,965,765)
Total Sum of Squares535367T

23Andme Total Liab History

2024316.4 M
2023206.6 M
2022228.7 M
2021236.4 M
2020B
2019270.4 M

About 23Andme Holding Financial Statements

23Andme Holding stakeholders use historical fundamental indicators, such as 23Andme Holding's Total Liab, to determine how well the company is positioned to perform in the future. Although 23Andme Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in 23Andme Holding's assets and liabilities are reflected in the revenues and expenses on 23Andme Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 23Andme Holding Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities206.6 M316.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of 23Andme Holding Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(122.52)
Revenue Per Share
8.224
Quarterly Revenue Growth
(0.34)
Return On Assets
(0.26)
Return On Equity
(1.54)
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.